Drugs / RG1511
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00517465 | Sep 2007 → Mar 2009 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RG1511 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00517465 ↗ |
| Route | Oral | “100mg po bid” NCT00517465 ↗ |